Papers
7
Total Citations
344
H-Index
7
About
Meixuan Li is a leading voice in the evidence-based evaluation of robotic-assisted surgery, with a career dedicated to sharpening the methodological rigor of surgical meta-analyses. Her research focuses on comparing robotic versus laparoscopic techniques across multiple specialties—including cholecystectomy, proctectomy for rectal cancer, and hepatectomy—where her work has systematically clarified clinical, pathological, and oncologic outcomes. Li’s landmark 2018 study, “The methodological quality of robotic surgical meta-analyses needed to be improved,” has garnered 117 citations, underscoring her role as a critical evaluator of research quality in the field. She has also pioneered scientometric approaches, mapping the top 100 most-cited publications in robotic versus laparoscopic surgery, and has advanced cost-utility analyses to assess the economic viability of robotic platforms. Notably, her 2022 work on cost-utility analyses calls for more rigorous reporting standards, reflecting her commitment to translating surgical innovation into practical, high-quality evidence. With over 340 cumulative citations, Li’s contributions are essential for surgeons, health economists, and researchers seeking trustworthy guidance on the adoption of robotic technology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6More work is needed on cost‐utility analyses of robotic‐assisted surgery22 citations · 2022
- 7